Trial Profile
Phase I trial of P 1101 for the treatment of hepatitis C and B
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 02 Feb 2010
Price :
$35
*
At a glance
- Drugs Ropeginterferon alfa-2b (Primary)
- Indications Hepatitis B; Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- Sponsors PharmaEssentia Corporation
- 02 Feb 2010 New trial record.